GenomeMe Lab Inc

GenomeMe is a biotechnology company specializing in immunohistochemistry (IHC) monoclonal antibodies and molecular diagnostic tools for cancer research and clinical applications

ISO9001
IHC Antibodies Mouse Monoclonal Antibodies Rabbit Monoclonal Antibodies Cancer Biomarker Antibodies qPCR Diagnostic Kits Genetic Testing Tools
Request quote Products Key techniques

Overview

GenomeMe Lab Inc. is a Canada-based biotechnology company founded around 2015, focused on developing molecular diagnostic tools and high-quality antibodies for clinical and research applications. The company specializes in immunohistochemistry (IHC) monoclonal antibodies, particularly mouse and rabbit-derived antibodies designed for cancer diagnostics and pathology workflows. GenomeMe differentiates itself by developing and manufacturing its antibodies entirely in-house, enabling strong control over quality, cost, and reproducibility. Its portfolio includes over 260+ clinical IHC antibodies, with ongoing expansion into molecular diagnostics such as qPCR-based cancer detection kits. The company is actively positioned in the growing field of precision diagnostics and molecular pathology, serving hospitals, diagnostic labs, and research institutions

IHC-based diagnostics, cancer biomarker detection, and molecular pathology workflows

Datasheets, validation reports, and clinical-grade documentation available for diagnostic antibodies

Custom antibody development and marker-specific solutions available

Key techniques

GenomeMe products support clinical and research workflows focused on pathology, cancer diagnostics, and molecular testing

Immunohistochemistry (IHC) qPCR (Quantitative PCR) Molecular Diagnostics Western Blot (WB) Immunoassays Biomarker Detection Pathology Staining

Product lines

GenomeMe offers a focused portfolio of diagnostic antibodies and molecular testing tools for clinical and research applications

Antibodies ›
Short scope summary + examples (optional).

Capabilities

GenomeMe integrates antibody engineering and molecular diagnostic technologies to support clinical and research workflows

  • Custom antibody development
  • Marker-specific assay design
  • Molecular diagnostic kit development
  • Collaboration with clinical labs

Products are manufactured under ISO 13485-certified quality systems and validated through external programs such as NordiQC

QC & documentation

GenomeMe provides clinical-grade validation and documentation for its diagnostic products

Certificates of Analysis available for antibody products

Material Safety Data Sheets available

Products are validated for clinical use, including CE-IVD certification and external proficiency testing

Lead time & shipping

Shipping timelines depend on product availability and customization

Many catalog antibodies are available for prompt shipment

Global shipping available

Temperature-controlled shipping for diagnostic reagents

Request a quote

Contact

Notes Technical support available for antibody selection, IHC optimization, and diagnostic assay development